The UK Government has announced that it will now offer the Pfizer Covid-19 vaccine to all children aged between 5 and 11 off the back of advice given by the Joint Committee on Vaccination and Immunisation (JCVI) to do so.
But with over 1.2 million adverse reactions including 2000 deaths reported to the MHRA Yellow Card Scheme as of 2nd Feb 22, questions are being asked of how the JCVI have come to the conclusion that the benefits of vaccination outweigh the risks.
It was only in July 2021 that the JCVI refused to recommend all children over the age of 12 should be offered the Covid-19 vaccine, because of justified fears over inflammation of the heart muscle (Myocarditis) linked to the Pfizer jab.
The JCVI were however, unfortunately ignored for the first time in history, with the Government urging the Chief Medical Officer for England, Chris Whitty to recommend that all children over 12 be offered the experimental jab, and so he did.
So why have the JCVI changed their tune just months later when it comes to children aged 5 to 11, who are at an even lower risk of developing serious disease due to Covid-19 than the already negligible risk among children aged 12 and over?
We suspect if you were to follow the money you would find out exactly why. But the decision to recommend the experimental jab be offered to children as young as 5 is nothing short of criminal because of the terrible risks associated with it.
You just have to look at the latest Yellow Card data published by the Medicine and Healthcare product Regulatory Agency (MHRA) to see why.
The MHRA publish a weekly report on adverse reactions that have been reported to the MHRA Yellow Card Scheme against the Covid-19 injections, and their latest report covers adverse reactions reported up to 2nd February 2022, and here’s what we found contained in the report for the Pfizer jab…